Efficacy and Safety of Off-Label Use of Fondaparinux in the Management of Heparin-Induced Thrombocytopenia With Thrombosis in an Elderly Woman

被引：2

作者：

Leporini, Christian ^{[1
,2
]}

Rende, Antonio ^{[3
]}

Sorrentino, Alfonso ^{[4
]}

Rizzica, Elvira ^{[5
]}

Russo, Emilio ^{[1
,2
]}

Gallelli, Luca ^{[1
,2
]}

De Sarro, Giovambattista ^{[1
,2
]}

机构：

[1] AO Mater Domini, Ctr Reg Informaz Farmaco, Catanzaro, Italy

[2] Univ Catanzaro, Sch Med, Dept Hlth Sci, Catanzaro, Italy

[3] San Francesco di Paola Hosp, Transfus Med Unit, Rome, Italy

[4] Tor Vergata Univ, Sch Med & Surg, Rome, Italy

[5] San Francesco di Paola Hosp, Farm Osped, Rome, Italy

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2013年 / 53卷 / 09期

关键词：

HIT; HITT; nadroparin; 4Ts score; Fondaparinux; ADVERSE DRUG-REACTIONS; RETROSPECTIVE ANALYSIS; PATIENT; ANTIBODIES; ULCERATION; HIT;

D O I：

10.1002/jcph.124

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：999 / 1002

页数：4

共 50 条

[31] Heparin-induced Thrombocytopenia As A Cause of Deep Venous Thrombosis: Effectiveness of Fondaparinux in Dialysis Patients
Taskapan, Hulya
Karahan, Dogu
Kuku, Irfan
Koc, Sait
TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2010, 19 (01): : 55 - 58
[32] HeparinLack of efficacy and heparin-induced thrombocytopenia and thrombosis: case report
Reactions Weekly, 2022, 1935 (1) : 213 - 213
[33] Management of Heparin-Induced Thrombocytopenia with Fondaparinux in a Patient with Left Ventricular Assist Device
Velagic, V.
Samardzic, J.
Baricevic, Z.
Skoric, B.
Cikes, M.
Gasparovic, H.
Biocina, B.
Milicic, D.
INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE, 2014, 5 (02): : 83 - 86
[34] Dalteparin sodiumAcute thrombocytopenia in an elderly patient with heparin-induced thrombocytopenia with thrombosis: case report
Reactions Weekly, 2002, 904 (1) : 7 - 7
[35] DABIGATRAN USE FOR MANAGEMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH CANCER-RELATED THROMBOSIS
Goncalves Ricca, L.
Carvalho, M.
Leite, A.
Fernandes, G.
Vasconcelos, F.
Koch, C.
THROMBOSIS RESEARCH, 2016, 141 : S73 - S73
[36] The Use of Fondaparinux for the Treatment of Deep Vein Thrombosis in a Patient With Heparin Induced Thrombocytopenia
Berrios-Colon, E.
Davanos, E.
Chou, A.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 29 (02) : 261 - 261
[37] EFFICACY AND SAFETY OF ORGARAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
TARDYPONCET, B
REYNAUD, J
TARDY, B
MAHUL, P
MISMETTI, P
DECOUSUS, H
GUYOTAT, D
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1323 - 1323
[38] Fondaparinux sodium/heparin/low-molecular-weight-heparinsHeparin-induced thrombocytopenia successfully treated with off-label therapy with fondaparinux sodium: case report
Reactions Weekly, 2018, 1724 (1) : 172 - 172
[39] REPLY: Fondaparinux and Direct Oral Anticoagulants Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia
Schindewolf, Marc
Banik, Norbert
Lindhoff-Last, Edelgard
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (15) : 1710 - 1712
[40] Quality, Safety and Efficacy in the 'Off-Label' Use of Medicines
Kairuz, Therese Eileen
Gargiulo, Derryn
Bunt, Craig
Garg, Sanjay
CURRENT DRUG SAFETY, 2007, 2 (01) : 89 - 95

← 1 2 3 4 5 →